Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S B Hwang

Showing results (51-60 of 73) with videos related to

Pageof 8
Sort By:
Journal of Virology|April 3, 1998
Hepatitis C virus core from two different genotypes has an oncogenic potential but is not sufficient for transforming primary rat embryo fibroblasts in cooperation with the H-ras oncogeneJ Chang, S H Yang, Y G Cho, et al.
Clinical Radiology|April 13, 2010
Comparison of gadoxetic acid-enhanced MRI and superparamagnetic iron oxide-enhanced MRI for the detection of hepatocellular carcinomaY K Kim, C S Kim, Y M Han, et al.
Journal of Medicinal Chemistry|January 1, 1987
Structure-activity relationships of kadsurenone analoguesM M Ponpipom, R L Bugianesi, D R Brooker, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 19, 1995
A pregnancy-specific glycoprotein is expressed in the brain and serves as a receptor for mouse hepatitis virusD S Chen, M Asanaka, K Yokomori, et al.
Journal of Viral Hepatitis|April 14, 2012
Nonstructural 5A protein of hepatitis C virus regulates heat shock protein 72 for its own propagationY S Lim, K S Shin, S H Oh, et al.
Diagnostic and Interventional Imaging|November 29, 2016
Acute carbon monoxide poisoning: MR imaging findings with clinical correlationD M Kim, I H Lee, J Y Park, et al.
Yao Xue Xue Bao = Acta Pharmaceutica Sinica|May 1, 1986
[Neolignans from Piper hancei Maxim]G Q Han, S M Li, C L Li, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 1, 1988
Biochemical and pharmacological characterization of L-659,989: an extremely potent, selective and competitive receptor antagonist of platelet-activating factorS B Hwang, M H Lam, A W Alberts, et al.
The Journal of Biological Chemistry|July 4, 1998
Hepatitis C virus core protein interacts with heterogeneous nuclear ribonucleoprotein KT Y Hsieh, M Matsumoto, H C Chou, et al.
Pharmacological Research|September 1, 2001
Anti-inflammatory activities of LDP-392, a dual PAF receptor antagonist and 5-lipoxygenase inhibitorC Qian, S B Hwang, L Libertine-Garahan, et al.
Pageof 8

Showing results (51-60 of 73) with videos related to

Sort By:
Pageof 8
Journal of Virology|April 3, 1998
Hepatitis C virus core from two different genotypes has an oncogenic potential but is not sufficient for transforming primary rat embryo fibroblasts in cooperation with the H-ras oncogeneJ Chang, S H Yang, Y G Cho, et al.
Clinical Radiology|April 13, 2010
Comparison of gadoxetic acid-enhanced MRI and superparamagnetic iron oxide-enhanced MRI for the detection of hepatocellular carcinomaY K Kim, C S Kim, Y M Han, et al.
Journal of Medicinal Chemistry|January 1, 1987
Structure-activity relationships of kadsurenone analoguesM M Ponpipom, R L Bugianesi, D R Brooker, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 19, 1995
A pregnancy-specific glycoprotein is expressed in the brain and serves as a receptor for mouse hepatitis virusD S Chen, M Asanaka, K Yokomori, et al.
Journal of Viral Hepatitis|April 14, 2012
Nonstructural 5A protein of hepatitis C virus regulates heat shock protein 72 for its own propagationY S Lim, K S Shin, S H Oh, et al.
Diagnostic and Interventional Imaging|November 29, 2016
Acute carbon monoxide poisoning: MR imaging findings with clinical correlationD M Kim, I H Lee, J Y Park, et al.
Yao Xue Xue Bao = Acta Pharmaceutica Sinica|May 1, 1986
[Neolignans from Piper hancei Maxim]G Q Han, S M Li, C L Li, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 1, 1988
Biochemical and pharmacological characterization of L-659,989: an extremely potent, selective and competitive receptor antagonist of platelet-activating factorS B Hwang, M H Lam, A W Alberts, et al.
The Journal of Biological Chemistry|July 4, 1998
Hepatitis C virus core protein interacts with heterogeneous nuclear ribonucleoprotein KT Y Hsieh, M Matsumoto, H C Chou, et al.
Pharmacological Research|September 1, 2001
Anti-inflammatory activities of LDP-392, a dual PAF receptor antagonist and 5-lipoxygenase inhibitorC Qian, S B Hwang, L Libertine-Garahan, et al.
Pageof 8